Skip to main content
SpringerLink
Log in

Testing pathophysiological hypotheses of Alzheimer’s disease and pharmacological modulation of amyloid precursor protein metabolism: the contribution from the studies on cultured fibroblasts from affected donors

  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Checler F.: Processing of the beta-amyloid precursor protein and its regulation in Alzheimer’s disease. J. Neurochem. 65: 1431–1444, 1995.

    Article  CAS  PubMed  Google Scholar 

  2. Govoni S., L. Gasparini, Racchi M. And Trabucchi M.: Peripheral cells as an investigational tool for Alzheimer’s disease. Life Sci. 59: 461–468, 1996.

    Article  CAS  PubMed  Google Scholar 

  3. Citron M., Vigo-Pelfrey C., Teplow D.B., et al.: Excessive production of amyloid ß-protein by peripheral cells of symptomatic and presymptomatic patients carrying the swedish familial Alzheimer disease mutation. Proc. Natl. Acad. Sci. USA 91: 11993–11997, 1994.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Scheuner D., Eckman C., Jensen M., et al.: Secreted amyloid ß-protein similar to that in the senile plaques of Alzheimer’s disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer’s disease. Nature Med. 2: 864–870, 1996.

    Article  CAS  PubMed  Google Scholar 

  5. Querfurth, H.W., Wijsman, E.M., St George-Hyslop, P.H., Selkoe D.J.: ßAPP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer’s disease-1 family. Mol. Brain Res. 28: 319–337, 1995.

    Article  CAS  PubMed  Google Scholar 

  6. Govoni S., Bergamaschi S., Gasparini L., et al.: Fibroblasts of patients affected by Down syndrome oversecrete amyloid precursor protein and are hyporesponsive to protein kinase C stimulation. Neurology 47: 1069–1075, 1996.

    Article  CAS  PubMed  Google Scholar 

  7. Bergamaschi S., Binetti G., Govoni S., et al.: Defective phorbol ester-stimulated secretion of beta-amyloid precursor protein from Alzheimer’s disease fibroblasts. Neurosci. Lett. 201: 1–4, 1995.

    Article  CAS  PubMed  Google Scholar 

  8. Racchi M, Govoni S., Baetta R., et al.: Secretory processing of amyloid precursor protein is inhibited by increase in plasma membran cholesterol content. Biochem. J. 322: 893–898, 1997.

    CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. IRCCS S.Giovanni di Dio, Sacred Heart Hospital -FBF-, Brescia, USA

    M. Racchi (Dr.), L. Gasparini, M. Trabucchi & S. Govoni

  2. Institute of Pharmacology, University of Pavia, Italy

    M. Racchi (Dr.), L. Gasparini, M. Trabucchi & S. Govoni

Authors
  1. M. Racchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Gasparini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Trabucchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Govoni
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Racchi, M., Gasparini, L., Trabucchi, M. et al. Testing pathophysiological hypotheses of Alzheimer’s disease and pharmacological modulation of amyloid precursor protein metabolism: the contribution from the studies on cultured fibroblasts from affected donors. Aging Clin Exp Res 9 (Suppl 4), 57–58 (1997). https://doi.org/10.1007/BF03339707

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03339707

Keywords

Search

Navigation